Navigation Links
Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
Date:6/2/2008

n Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

CONTACT:

Kristen Woodward

206-667-5095

kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...GRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,...romboticaptamerswithactivecontrolagents,announcedt...atthePiperJaffray21stAnnualHealthCareConferenceatt...tationwillbegivenat1:10pm(EST)onTuesday,December1a...mphasisontheleaddevelopmentprogram,theanticoagulan...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 1Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 2Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 3Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 4Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 5Webcast Alert 3A Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA 6184 1Webcast Alert 3A Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA 6184 2Understanding mechanical properties of silicon nanowires paves way for nanodevices 14797 1Understanding mechanical properties of silicon nanowires paves way for nanodevices 14797 2
...erumo Heart, Inc. announced,today that they have r...g,Administration (FDA) to begin enrollment in the ...Bridge-to-Transplant (BTT) indication., (Logo: h...3LOGO ), (Photo: http://www.newscom.com/cgi-bin...President of Clinical Studies, Regulatory,Affairs ...
...9 Eisai Corporation of,North America, a wholly-ow...unced today that the Food and Drug Administration ...g Application (sNDA) for the short-term (up to,eig...ease (GERD) in,patients ages 12-16. Further, FDA h...eview in accordance with the Best Pharmaceuticals ...
Other Medicine Technology:DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial 2FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents 2
(Date:11/25/2009)...,, BroadPoliticalEndorsements,Business,andPres...RNewswire-USNewswire/--Onceagain,theNationalBipola...amationendorsingtheir"Safe,tilStable"program,which...sureforbipolardisorder.Today,theNationalBipolarFou...lExpressPriorityMailfromtheLt.GovernorofLouisianaM...
(Date:11/25/2009)...t study follow-up period was too short to draw def...NESDAY, Nov. 25 (HealthDay News) -- In diabetic pa...rs to be no difference in outcomes at one year whe...y with stenting, British researchers report. , ... diabetic patients with coronary artery disease. H...
(Date:11/25/2009)... more positive note, CDC sees few signs of trouble...Nov. 25 (HealthDay News) -- The ongoing H1N1 swine...gerous pneumonias among younger patients, a U.S. h... an increase in serious pneumococcal infections ar...the National Center for Immunization and Respirato...
(Date:11/25/2009)...A drug used to treat colorectal cancer also can re...ered first-line therapy for the disease, researche...this week. , Mntrier,s disease causes thickening ...ea and vomiting, as well as anemia and swelling in... are at increased risk for gastric cancer. Previou...
(Date:11/25/2009)... Initiative expands to incl...for students, teachers, and healthcare professiona... Pleasanton, CA (PRWEB) November 25, 2009 -- Ellu...d social networking solutions that support 21st c...unced today that its Fire and Ice initiative was...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
...enced by cancer patients undergoing high-dose chem...sea and vomiting caused by the powerful drugs used...for patients. Doctors offer an arsenal of va...ncture involves the insertion of tiny needles at v...
...ness is being collected on a database which both d...ngredient in medical research is the patient's voi...ms, but doctors and researchers could learn a lot ...information on managing their condition. // ...
... treat the neurological problems that are common i... US suffer from kidney failure, which is usually c...n. Kidney failure often leads to neurological comp...ve learned more of the origin of the neurological ...
...overing a gene that may influence the risk of oeso...s helping Cancer Research Campaign scientists lear...hagus. Twenty one members of this family have died...udying 350 members of the extended Liverpool famil...
...s in your diet can affect your vision, according t...MD) is a currently untreatable disease of the eye ...rment. As the name suggests, it gets worse with ag...als aged 55 to 80 with AMD, and compared their die...
...dilation of a blood vessel. This involves all laye...alth due to their potential to rupture, thrombose ...d are the abdominal and thoracic aorta, and brain.... are born with a malformation of a blood vessel wi...
Other Medicine News:
... Record system is a family of solutions designed t...entity, longitudinal electronic medical record (EM...to one desktop application that provides access to... record. , By combining all the essential elemen...
EncounterPRO Electronic Health Record
SOAPware The Electronic Health Record
...e efficiency and quality of patient care. It offer...patient information whether it is in text, image, ...cord application, it provides a familiar contempor...icrosoft Office applications. In addition, VersaSu...
Medicine Products: